(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
As infant botulism cases climb to 31, recalled ByHeart baby formula is still on some store shelves - 2NASA’s Pandora telescope will study stars in detail to learn about the exoplanets orbiting them
- 3Iran plans new restrictions in overhaul of Strait of Hormuz rules
- 4Saucony's $125 'Comfy, Stylish' Sneakers Are Now $55
- 5What's your #1 tone
- 6 Eyewear Brands Worth Purchasing
- Must-See Attractions in Australia
- Four countries to boycott Eurovision 2026 over Israel’s inclusion
- Hundreds of Gazans evacuated from Strip for medical treatment - COGAT
- Trump administration launches new immigration crackdowns in New Orleans and Minneapolis. Here are all the cities it has targeted so far.
- The most effective method to Apply Antiquated Ways of thinking in Current Brain science Practices
- Investigating Remarkable Espresso Flavors: Upgrade Your Day to day Blend
- NASA’s Artemis II mission will take an astronaut crew around the Moon – a space policy expert describes the long road to launch
- 'Stranger Things' series finale trailer shows Hawkins gang gearing up for last battle with Vecna
